![]() |
市場調查報告書
商品編碼
1499544
醫療保健契約製造市場:按製造類型、最終用戶分類 - 2024-2030 年全球預測Healthcare Contract Manufacturing Market by Manufacturing Type (Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing), End-Users (Medical Device Companies, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年醫療保健契約製造市場規模為1,860億美元,預計2024年將達2016.8億美元,2030年將達3,292.2億美元,複合年成長率為8.49%。
醫療保健契約製造市場由向其他醫療保健組織提供各種服務的公司組成,從藥物處方和市場開拓到製造醫療保健設備和組件。這個市場允許醫療保健公司外包部分業務,降低成本,提高靈活性,並利用先進的製造技術和專業知識。推動該市場成長的關鍵因素包括對學名藥的需求增加、慢性病的流行、對先進醫療設備的需求以及新治療方式的快速採用。然而,嚴格的監管合規性、各種國際標準以及在降低成本的同時保持高品質流程的壓力是阻礙市場成長的主要阻礙因素。醫療保健契約製造市場的機會是由技術進步驅動的,例如設備製造中的 3D 列印、個人化醫療保健以及日益重要的監管合規性。此外,持續投資研發創新生技藥品和醫療保健設備並適應不斷發展的數位醫療保健格局可能會進一步加劇市場競爭。
主要市場統計 | |
---|---|
基準年[2023] | 1860億美元 |
預測年份 [2024] | 2016.8億美元 |
預測年份 [2030] | 3292.2億美元 |
複合年成長率(%) | 8.49% |
區域洞察
由於其高度發達的醫療基礎設施和嚴格的監管要求,美洲正在經歷顯著的市場成長。由於越來越注重降低醫療保健成本,北美地區對受託製造廠商(CMO) 的外包(尤其是藥品和醫療保健設備)正在迅速增加。由於政府的大力支持以及學術界和工業界的合作,歐洲國家處於醫療保健研究和開發的前沿。公共和私營部門在個人化醫療、基因組學、數位健康解決方案和先進療法等領域的投資不斷增加,進一步支持了歐洲、中東和非洲醫療保健契約製造的成長。由於國內需求成長、成本優勢和技術進步,中國、日本和印度的醫療保健契約製造正在顯著成長。亞太地區正在成為醫療保健設備和藥品的製造地,導致受託製造公司在亞太市場的策略擴張。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在醫療保健契約製造市場中的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對醫療保健契約製造市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該細分市場競爭力的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在醫療保健契約製造市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[190 Pages Report] The Healthcare Contract Manufacturing Market size was estimated at USD 186.00 billion in 2023 and expected to reach USD 201.68 billion in 2024, at a CAGR 8.49% to reach USD 329.22 billion by 2030.
The healthcare contract manufacturing market comprises firms that offer a range of services, from drug formulation and development to medical devices and components manufacturing for other healthcare organizations. This market enables healthcare companies to outsource certain aspects of their operations, which can lead to lowered costs, increased flexibility, and access to advanced manufacturing technologies and expertise. The major factors propelling the growth of the healthcare contract manufacturing market include the increasing demand for generic medicines, the rising prevalence of chronic diseases, the need for advanced medical devices, and the surge in the introduction of new therapeutic methodologies. However, stringent regulatory compliances, varying international standards, and the pressure of maintaining high-quality processes while reducing costs are the major restraining factors hindering market growth. The opportunities within the healthcare contract manufacturing market are driven by technological advancements such as 3D printing in device manufacturing, personalized medicine, and the growing importance of regulatory compliance. Additionally, sustained investments in R&D for developing innovative biologics and medical devices and adapting to the evolving digital healthcare landscape could further enhance market competitiveness.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 186.00 billion |
Estimated Year [2024] | USD 201.68 billion |
Forecast Year [2030] | USD 329.22 billion |
CAGR (%) | 8.49% |
Regional Insights
The Americas has significant market growth due to highly developed healthcare infrastructure and stringent regulatory requirements in the region. The increased focus on bringing down healthcare costs has led to a surge in outsourcing to contract manufacturing organizations (CMOs), particularly for pharmaceuticals and medical devices in the North American region. European Countries are at the forefront of healthcare research and development, bolstered by strong government support and collaborations between academia and industry. The growing investments from the public and private sectors in areas such as personalized medicine, genomics, digital health solutions, and advanced therapies further drive the growth of healthcare contract manufacturing in the EMEA region. China, Japan, and India are witnessing significant growth in healthcare contract manufacturing due to rising domestic demand, cost advantages, and technological advances. The Asia Pacific (APAC) region has emerged as a medical device and pharmaceutical manufacturing hub, leading to strategic business expansions by contract manufacturing organizations in the APAC market.
Market Insights
The market dynamics represent an ever-changing landscape of the Healthcare Contract Manufacturing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Healthcare Contract Manufacturing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Healthcare Contract Manufacturing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Biomerics Announces Merger with Precision Concepts Medical
Biomerics LLC, a major player in vertically integrated contract manufacturing in the interventional medical device sector, has announced its strategic merger with Precision Concepts Medical. This significant transaction encompasses the acquisition of Precision Concepts International's (PCI) medical business and Precision Concepts Group (PCG), headquartered in Winston-Salem, North Carolina. This merger between Biomerics LLC and Precision Concepts Medical strengthened their presence in the healthcare contract manufacturing landscape. [Published On: 2023-05-17]
PCI Pharma Unveils Plans for USD 50 Millions Expansion At Illinois Injectables Site
PCI Pharma Services, a biopharmaceutical contract manufacturing organization, recently announced its plans for a significant USD 50 million expansion at its Rockford, Illinois-based sterile injectables facility. The project is expected to involve the construction of a state-of-the-art 200,000-square-foot site that aims to substantially enhance the plant's production capacity for injectable drug-device combination products. The ambitious expansion initiative underscores PCI Pharma Services' commitment to addressing the growing demand for high-quality sterile injectable solutions while maintaining its position as a trusted and reliable partner in the biopharmaceutical sector. [Published On: 2023-03-16]
Medisurge and Signal Medical Announce Strategic Partnership
Medisurge, a healthcare contract manufacturing player, has announced its exclusive partnership with Signal Medical Corporation. Signal Medical has built a solid reputation for manufacturing high-quality knee and hip implants and providing advanced instrument systems to orthopedic surgeons. This strategic partnership between Medisurge and Signal Medical facilitates growth expansion for both companies in the competitive orthopedic market. By combining their expertise and resources, the partnership aims to establish an even stronger presence and provide enhanced services to clients within the industry. [Published On: 2023-01-25]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Healthcare Contract Manufacturing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Healthcare Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Group, Almac Group, Baxter International, Inc., Biozoc Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Curia Global, Inc., Evonik Industries AG, Famar Group, Jubilant Biosys Limited, Lonza Group Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Pidolma Healthcare Private Limited, Recipharm AB, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage